Company intelligence / Profile preview

Global Humanceuticals

Boca Raton, Florida, United States

Ownership: Private
Development stage: Other

Overview

Global Humanceuticals was a biotechnology company that specialized in the development and commercialization of recombinant human growth hormone (rhGH) therapies. The company's flagship product, GH-1, was a somatropin-based biologic produced via recombinant DNA technology, intended for patients with growth hormone deficiencies and other metabolic disorders. Headquartered in Boca Raton, Florida, Global Humanceuticals operated within the specialty pharmaceutical and endocrinology sectors. The company is currently inactive, having been dissolved in 2012, but it remains cited in historical market analyses of the global growth hormone industry.

Therapeutic areas: Endocrinology
Modalities: Recombinant proteinProtein
Industry: Biotech

Beyond the preview

Go deeper on Global Humanceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Global Humanceuticals.

Explore the full profile